This audio is auto-generated. Please let us know if you have feedback.
Here are some of the latest facility announcements to kick off 2026:
- Kratos, a technology company in defense, national security and global markets, announced the opening of a 55,000-square-foot hypersonic and “other” system manufacturing and payload integration facility in Princess Anne, Maryland. According to the company, the facility will significantly enhance Kratos’ ability to support launch operations and hypersonic testing for its $1.4 billion contract with the Multi-Service Advanced Capability Hypersonics Test Bed 2.0 program. Other customers include the U.S. Navy, U.S. Air Force, DARPA, and Missile Defense Agency. In particular, the facility will increase production capacity and streamline payload integration processes, Dave Carter, president of Kratos’ Defense & Rocket Support Services Division, said in a news release.
- Bombardier announced a new 126,000-square-foot manufacturing center for business aircraft in Dorval, Montreal. The building, set to open at the end of 2027 near two other company facilities, will expand Bombardier’s industrial footprint and strengthen its production capabilities, according to a news release. The project is part of a long-term strategy to boost productivity and respond to growing demand for business aircraft.
- Becton, Dickinson and Co. said it will spend more than $110 million to expand a prefilled flush syringe manufacturing facility in Columbus, Nebraska to better meet growing demand for biologic drugs. In a news release, the company said the capital will go toward establishing production of its BD Neopak Glass Prefillable Syringes platform at the 76-year-old site. In addition, BD is investing $10 million to enhance cannula manufacturing capabilities at the site, and together these investments will add approximately 120 new jobs. The BD Neopak Glass Prefillable Syringes platform supports a wide range of formulation requirements and features auto-injectors to allow flexible, patient-centric drug delivery in both clinical and at-home settings. The expansion comes about five months after BD revealed its plans to spend more than $35 million to increase prefilled flush syringe manufacturing in Columbus and create 50 new jobs.
